Empowering appropriate antimicrobial use with rapid diagnostics.

News Articles

Keep up to date with the latest news and reports on antimicrobial resistance from around the world as well as industry published articles about Test Target Treat and rapid diagnostics.

Antimicrobial Resistance News

Alere Hosts Event Responding to Challenge of Antimicrobial Resistance (AMR) in Ireland

Mar. 08, 2017: The high-level, multi-stakeholder roundtable event explored the uptake of antimicrobial stewardship policy… Read More

United Nations Establishes Interagency Coordination Group on Antimicrobial Resistance

On 21 September 2016, world leaders gathered at the United Nations General Assembly in New York… Read More

WHO today published its first ever list of bacteria that pose the greatest threat to human health

On February 27th WHO published its first ever list of antibiotic-resistant "priority pathogens"… Read More

Antibiotic resistance rising in Europe

A new report on antimicrobial resistance from the European Centre for Disease Prevention and Control… Read More

First recorded cases of frontline malaria drug failing to treat UK patients

For the first time, cases of resistance to anti-malaria drugs have been reported in the UK… Read More

Davos 2017: Committing to Diagnostic Solutions to Tackle Antimicrobial Resistance

Diagnostics Industry leaders will come together during the World Economic Forum (WEF) Annual Meeting in Davos-Klosters… Read More

Alere promotes Antimicrobial Stewardship with “Antibiotics Rapid Action Week”

2016 has seen the threat of Antimicrobial Resistance receive the widespread attention it deserves, including the publication… Read More

Antibiotic Resistance is highlighted at U.N. General Assembly

On 21 September 2016, world leaders gathered at the United Nations General Assembly in New York to commit to fighting antimicrobial resistance… Read More

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics

In the first study to investigate point-of-care CRP in low-income or middle-income countries, tests were provided to 10 primary healthcare centers… Read More

Alere™ Reader achieves In-Vitro Diagnostic (IVD) CE marking in Europe

Alere has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere™ Reader*, a diagnostic analyzer… Read More

Review on Antimicrobial Resistance recognises rapid diagnostics as integral to the AMR Global Strategy

In July 2014, the UK Government commissioned the Review on Antimicrobial Resistance in collaboration with the Wellcome Trust… Read More

What to expect from Alere at ECCMID 2016

Alere is pleased to once again be attending the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam… Read More

GP practice wins Innovation Challenge award for use of Alere Afinion CRP

The NHS Innovation Challenge Prizes took place on 28 January 2016. The challenge seeks to encourage, recognize and reward… Read More

Alere among 85 companies to sign Declaration Combating Antimicrobial Resistance in Davos

The Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance was launched… Read More

Alere promotes Antimicrobial Stewardship with Week of Global Action

As part of our commitment to the promotion of Antibiotic Stewardship, Alere is proud to announce a Week of Global Action… Read More

New report calls for new rapid diagnostics to stop unnecessary use of antibiotics and tackle superbugs

In a report published 23 October 2015, Jim O’Neill’s Review on Antimicrobial Resistance sets out proposals… Read More

Alere Receives FDA CLIA Waiver for Alere™ i Strep A Rapid Molecular Test

The U.S. Food and Drug Administration (FDA) has granted CLIA waiver for the Alere™ i Strep A test… Read More

Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum

Alere joined the White House Antibiotic Stewardship Forum to announce a set of commitments to combat antibiotic-resistant bacteria… Read More

Alere Receives FDA CLIA Waiver for Alere™ i Influenza
A & B Test

Alere announced that the U.S. Food and Drug Administration (FDA) has granted CLIA waiver for the Alere™ i Influenza A & B test, the only molecular test to detect and differentiate influenza A and B virus in under 15 minutes… Read More

Alere Applauds President Obama’s Executive Order Combating Antibiotic-Resistant Bacteria

As the global leader in rapid diagnostics for infectious disease, we commend the President for establishing a national strategy… Read More

World Health Organization (WHO) Global Report on Antibiotic Resistance

The report reveals that this serious threat is no longer a prediction for the future; it is happening right now in every region of the world… Read More

Test Target Treat Making Headlines

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Alere or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Alere or TestTargetTreat.com. Neither Alere nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.